TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

Name: TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer
License: Public Domain

Fujian Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

colorectal-cancer immunotherapy

immunotherapy, colorectal cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 238096
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.